Literature DB >> 25093433

Reply: Translation of regenerative technologies into clinical paradigms.

Atta Behfar1, Ruben Crespo-Diaz1, Andre Terzic1, Bernard J Gersh1.   

Abstract

Mesh：

Year:  2014        PMID： 25093433     DOI： 10.1038/nrcardio.2014.9-c2

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  15 in total

1.  Emerging innovation towards safety in the clinical application of ESCs and iPSCs.

Authors:  Shigeo Masuda; Shigeru Miyagawa; Satsuki Fukushima; Nagako Sougawa; Emiko Ito; Maki Takeda; Atsuhiro Saito; Yoshiki Sawa
Journal:  Nat Rev Cardiol       Date:  2014-08-05       Impact factor: 32.419

2.  Managing the innovation supply chain to maximize personalized medicine.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2014-02       Impact factor: 6.875

3.  Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

Authors:  Jozef Bartunek; Atta Behfar; Dariouch Dolatabadi; Marc Vanderheyden; Miodrag Ostojic; Jo Dens; Badih El Nakadi; Marko Banovic; Branko Beleslin; Mathias Vrolix; Victor Legrand; Christian Vrints; Jean Louis Vanoverschelde; Ruben Crespo-Diaz; Christian Homsy; Michal Tendera; Scott Waldman; William Wijns; Andre Terzic
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

4.  Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.

Authors:  Birgit Assmus; Dirk H Walter; Florian H Seeger; David M Leistner; Julia Steiner; Ina Ziegler; Andreas Lutz; Walaa Khaled; Jens Klotsche; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  JAMA       Date:  2013-04-17       Impact factor: 56.272

Review 5.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies.

Authors:  Andrew S Lee; Chad Tang; Mahendra S Rao; Irving L Weissman; Joseph C Wu
Journal:  Nat Med       Date:  2013-08-06       Impact factor: 53.440

Review 6.  Cell therapy for cardiac repair--lessons from clinical trials.

Authors:  Atta Behfar; Ruben Crespo-Diaz; Andre Terzic; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2014-03-04       Impact factor: 32.419

7.  Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).

Authors:  Konstantinos Malliaras; Raj R Makkar; Rachel R Smith; Ke Cheng; Edwin Wu; Robert O Bonow; Linda Marbán; Adam Mendizabal; Eugenio Cingolani; Peter V Johnston; Gary Gerstenblith; Karl H Schuleri; Albert C Lardo; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2013-09-11       Impact factor: 24.094

8.  Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.

Authors:  Philippe Menasché; Valérie Vanneaux; Jean-Roch Fabreguettes; Alain Bel; Lucie Tosca; Sylvie Garcia; Valérie Bellamy; Yohan Farouz; Julia Pouly; Odile Damour; Marie-Cécile Périer; Michel Desnos; Albert Hagège; Onnik Agbulut; Patrick Bruneval; Gérard Tachdjian; Jean-Hugues Trouvin; Jérôme Larghero
Journal:  Eur Heart J       Date:  2014-05-16       Impact factor: 29.983

Review 9.  The advancing field of cell-based therapy: insights and lessons from clinical trials.

Authors:  Kartik S Telukuntla; Viky Y Suncion; Ivonne H Schulman; Joshua M Hare
Journal:  J Am Heart Assoc       Date:  2013-10-10       Impact factor: 5.501

10.  Cardiopoietic programming of embryonic stem cells for tumor-free heart repair.

Authors:  Atta Behfar; Carmen Perez-Terzic; Randolph S Faustino; D Kent Arrell; Denice M Hodgson; Satsuki Yamada; Michel Puceat; Nicolas Niederländer; Alexey E Alekseev; Leonid V Zingman; Andre Terzic
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.